Hypercoagulability, D-dimer and atrial fibrillation: an overview of biological and clinical evidence

References

• Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics–2013 update: a report from the American Heart Association. Circulation. 2013;127:e6–245.
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener HC, et al. Outcome parameters for trials in atrial fibrillation: executive summary. Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). Eur Heart J. 2007;28:2803–17.
   PubMed Web of Science ®Google Scholar
• Franco D, Chinchilla A, Aránega AE. Transgenic insights linking pitx2 and atrial arrhythmias. Front Physiol. 2012;3:206.
   Google Scholar
• Benjamin EJ, Rice KM, Arking DE, Pfeufer A, van Noord C, Smith AV, et al. Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet. 2009;41:879–81.
   PubMed Web of Science ®Google Scholar
• Ellinor PT, Lunetta KL, Glazer NL, Pfeufer A, Alonso A, Chung MK, et al. Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet. 2010;42:240–4.
   PubMed Web of Science ®Google Scholar
• Ellinor PT, Lunetta KL, Albert CM, Glazer NL, Ritchie MD, Smith AV, et al. Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet. 2012;44:670–5.
   PubMed Web of Science ®Google Scholar
• Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al.; ESC Committee for Practice Guidelines (CPG). 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33:2719–47.
   PubMed Web of Science ®Google Scholar
• Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, et al.; ASSERT Investigators. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366:120–9.
   PubMed Web of Science ®Google Scholar
• Verma A, Champagne J, Sapp J, Essebag V, Novak P, Skanes A, et al. Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study. JAMA Intern Med. 2013;173:149–56.
   PubMed Web of Science ®Google Scholar
• Jahangir A, Lee V, Friedman PA, Trusty JM, Hodge DO, Kopecky SL, et al. Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study. Circulation. 2007;115: 3050–6.
   PubMed Web of Science ®Google Scholar
• Soliman EZ, Safford MM, Muntner P, Khodneva Y, Dawood FZ, Zakai NA, et al. Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med. 2014;174:107–14.
   PubMed Web of Science ®Google Scholar
• Dukes JW, Marcus GM. Atrial fibrillation begets myocardial infarction. JAMA Intern Med. 2014;174:5–7.
   PubMed Web of Science ®Google Scholar
• Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol. 2003; 91:2D–8D.
   PubMed Web of Science ®Google Scholar
• Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003;107:2920–5.
   PubMed Web of Science ®Google Scholar
• Lip GY. Does atrial fibrillation confer a hypercoagulable state?Lancet. 1995;346:1313–14.
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Takahashi A, Kuwahara T, Okubo K, Fujino T, Takagi K, et al. Renal function after catheter ablation of atrial fibrillation. Circulation. 2011;124:2380–7.
   PubMed Web of Science ®Google Scholar
• Bansal N, Fan D, Hsu CY, Ordonez JD, Marcus GM, Go AS. Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease. Circulation. 2013;127:569–74.
   PubMed Web of Science ®Google Scholar
• Hijazi Z, Oldgren J, Siegbahn A, Granger CB, Wallentin L. Biomarkers in atrial fibrillation: a clinical review. Eur Heart J. 2013; 34:1475–80.
   PubMed Web of Science ®Google Scholar
• Choudhury A, Lip GY. Atrial fibrillation and the hypercoagulable state: from basic science to clinical practice. Pathophysiol Haemost Thromb. 2003–2004;33:282–9.
   PubMedGoogle Scholar
• Lippi G, Franchini M. Pathogenesis of venous thromboembolism: when the cup runneth over. Semin Thromb Hemost. 2008;34:747–61.
   PubMed Web of Science ®Google Scholar
• Miyazaki S, Ito T, Suwa M, Nakamura T, Kobashi A, Kitaura Y. Role of transesophageal echocardiography in the prediction of thromboembolism in patients with chronic nonvalvular atrial fibrillation. Jpn Circ J. 2001;65:874–8.
   PubMedGoogle Scholar
• Kamp O, Verhorst PM, Welling RC, Visser CA. Importance of left atrial appendage flow as a predictor of thromboembolic events in patients with atrial fibrillation. Eur Heart J. 1999;20:979–85.
   PubMed Web of Science ®Google Scholar
• Sanfilippo AJ, Abascal VM, Sheehan M, Oertel LB, Harrigan P, Hughes RA, et al. Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. Circulation. 1990; 82:792–7.
   PubMed Web of Science ®Google Scholar
• Keren G, Etzion T, Sherez J, Zelcer AA, Megidish R, Miller HI, et al. Atrial fibrillation and atrial enlargement in patients with mitral stenosis. Am Heart J. 1987;114:1146–55.
   PubMed Web of Science ®Google Scholar
• Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators. Ann Intern Med. 1992;116:6–12.
   Google Scholar
• Watson T, Shantsila E, Lip GY. Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited. Lancet. 2009;373:155–66.
   PubMed Web of Science ®Google Scholar
• Goldsmith IR, Blann AD, Patel RL, Lip GY. Von Willebrand factor, fibrinogen, and soluble P-selectin levels after mitral valve replacement versus mitral valve repair. Am J Cardiol. 2000;85:1218–22.
   Google Scholar
• Blackshear JL, Pearce LA, Hart RG, Zabalgoitia M, Labovitz A, Asinger RW, et al.; for the Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Aortic plaque in atrial fibrillation: prevalence, predictors, and thromboembolic implications. Stroke. 1999;30:834–40.
   PubMed Web of Science ®Google Scholar
• Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Ann Intern Med. 1998;128:639–47.
   PubMed Web of Science ®Google Scholar
• Kaski JC, Arrebola-Moreno AL. Inflammation and thrombosis in atrial fibrillation. Rev Esp Cardiol. 2011;64:551–3.
   PubMed Web of Science ®Google Scholar
• Boos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder?Eur Heart J. 2006;27:136–49.
   PubMed Web of Science ®Google Scholar
• Chung NA, Belgore F, Li-Saw-Hee FL, Conway DS, Blann AD, Lip GY. Is the hypercoagulable state in atrial fibrillation mediated by vascular endothelial growth factor?Stroke. 2002;33:2187–91.
   PubMed Web of Science ®Google Scholar
• Marin F, Roldan V, Climent V, Garcia A, Marco P, Lip GY. Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor TIMP-1?Stroke. 2003;34:1181–6.
   PubMed Web of Science ®Google Scholar
• Conway DS, Pearce LA, Chin BS, Hart RG, Lip GY. Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation. Circulation. 2002;106:1962–7.
   PubMed Web of Science ®Google Scholar
• Kamath S, Blann AD, Lip GY. Platelets and atrial fibrillation. Eur Heart J. 2001;22:2233–42.
   PubMedGoogle Scholar
• López-Cuenca A, Marín F, Roldán V, González-Conejero R, Hernández-Romero D, Valdés M, et al. Genetic polymorphisms and atrial fibrillation: insights into the prothrombotic state and thromboembolic risk. Ann Med. 2010;42:562–75.
   PubMed Web of Science ®Google Scholar
• Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31:2369–429.
   PubMed Web of Science ®Google Scholar
• Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. Chest. 2010;137:263–72.
   PubMed Web of Science ®Google Scholar
• Lippi G, Cervellin G, Franchini M, Favaloro EJ. Biochemical markers for the diagnosis of venous thromboembolism: the past, present and future. J Thromb Thrombolysis. 2010;30:459–71.
   PubMed Web of Science ®Google Scholar
• Lippi G, Franchini M, Targher G, Favaloro EJ. Help me, Doctor! My D-dimer is raised. Ann Med. 2008;40:594–605.
   PubMed Web of Science ®Google Scholar
• Lip GY, Lowe GD, Rumley A, Dunn FG. Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis. Am Heart J. 1996; 131:724–30.
   PubMed Web of Science ®Google Scholar
• Marin F, Roldan V, Climent VE, Ibanez A, Garcia A, Marco P, et al. Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation. Heart. 2004;90:1162–6.
   PubMed Web of Science ®Google Scholar
• Inoue H, Nozawa T, Okumura K, Lee JD, Shimizu A, Yano K. Prothrombotic activity is increased in patients with nonvalvular atrial fibrillation and risk factors for embolism. Chest. 2004;126:687–92.
   PubMed Web of Science ®Google Scholar
• Lip GY, Lowe GDO, Rumley A, Dunn FG. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin therapy. Br Heart J. 1995;73:527–33.
   PubMedGoogle Scholar
• Sadanaga T, Mitamura H, Fukuda K, Ogawa S. D-dimer levels positively correlate with B-type natriuretic peptide levels in patients with atrial fibrillation. Int J Cardiol. 2012;158:110–11.
   Google Scholar
• Lippi G, Cervellin G, Casagranda I, Morelli B, Testa S, Tripodi A. D-dimer testing for suspected venous thromboembolism in the emergency department. Consensus document of AcEMC, CISMEL, SIBioC, and SIMeL. Clin Chem Lab Med. 2014;52:621–8.
   PubMed Web of Science ®Google Scholar
• Verma N, Willeke P, Bicsán P, Lebiedz P, Pavenstädt H, Kümpers P. Age-adjusted D-dimer cut-offs to diagnose thromboembolic events. Validation in an emergency department. Med Klin Intensivmed Notfmed. 2014;109:121–8. [German]
   Google Scholar
• Lippi G, Bonfanti L, Saccenti C, Cervellin G. Causes of elevated D-dimer in patients admitted to a large urban emergency department. Eur J Intern Med. 2014;25:45–8.
   PubMed Web of Science ®Google Scholar
• Douma RA, Tan M, Schutgens RE, Bates SM, Perrier A, Legnani C, et al. Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded. Haematologica. 2012;97:1507–13.
   PubMed Web of Science ®Google Scholar
• Penaloza A, Roy P-M, Kline J, Verschuren F, Le Gal G, Quentin-Georget S, et al. Performance of age-adjusted D-dimer cut-off to rule out pulmonary embolism. J Thromb Haemost. 2012;10:1291–6.
   PubMed Web of Science ®Google Scholar
• Schouten HJ, Geersing GJ, Koek HL, Zuithoff NPA, Janssen KJM, Douma RA, et al. Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients with suspected venous thromboembolism: systematic review and meta-analysis. BMJ. 2013;346:f2492.
   PubMed Web of Science ®Google Scholar
• Legnani C, Cini M, Cosmi B, Carraro P, Tripodi A, Erba N, et al. Age and gender specific cut-off values to improve the performance of D-dimer assays to predict the risk of venous thromboembolism recurrence. Intern Emerg Med. 2013;8:229–36.
   PubMed Web of Science ®Google Scholar
• Gallagher MM, Hennessy BJ, Edvardsson N, Hart CM, Shannon MS, Obel OA, et al. Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion. J Am Coll Cardiol. 2002;40:926–33.
   PubMed Web of Science ®Google Scholar
• Yasaka M, Miyatake K, Mitani M, Beppu S, Nagata S, Yamaguchi T, et al. Intracardiac mobile thrombus and D-dimer fragment of fibrin in patients with mitral stenosis. Br Heart J. 1991;66:22–5.
   Google Scholar
• Heppell RM, Berkin KE, McLenachan JM, Davies JA. Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation. Heart. 1997;77:407–11.
   PubMed Web of Science ®Google Scholar
• Somloi M, Tomcsanyi J, Nagy E, Bodó I, Bezzegh A. D-dimer determination as a screening tool to exclude atrial thrombi in atrial fibrillation. Am J Cardiol. 2003;92:85–7.
   Google Scholar
• Habara S, Dote K, Kato M, Sasaki S, Goto K, Takemoto H, et al. Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation. Eur Heart J. 2007;28:2217–22.
   PubMed Web of Science ®Google Scholar
• Body R, Allie B. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Negative D-dimer may allow safe early cardioversion of atrial fibrillation. Emerg Med J. 2007;24:432–5.
   Google Scholar
• Mahé I, Bergmann JF, Chassany O, dit-Sollier CB, Simoneau G, Drouet L; COAGFA Group. A multicentric prospective study in usual care: D-dimer and cardiovascular events in patients with atrial fibrillation. Thromb Res. 2012;129:693–9.
   Google Scholar
• Mahé I, Drouet L, Simoneau G, Minh-Muzeaux S, Caulin C, Bergmann JF. D-dimer can predict survival in patients with chronic atrial fibrillation. Blood Coagul Fibrinolysis. 2004;15:413–17.
   Google Scholar
• Krarup LH, Sandset EC, Sandset PM, Berge E. D-dimer levels and stroke progression in patients with acute ischemic stroke and atrial fibrillation. Acta Neurol Scand. 2011;124:40–4.
   PubMed Web of Science ®Google Scholar
• Roldán V, Marín F, Muiña B, Torregrosa JM, Hernández-Romero D, Valdés M, et al. Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients. J Am Coll Cardiol. 2011;57:2496–504.
   PubMed Web of Science ®Google Scholar
• Sadanaga T, Sadanaga M, Ogawa S. Evidence that D-dimer levels predict subsequent thromboembolic and cardiovascular events in patients with atrial fibrillation during oral anticoagulant therapy. J Am Coll Cardiol. 2010;55:2225–31.
   PubMed Web of Science ®Google Scholar
• Sadanaga T, Kohsaka S, Ogawa S. D-dimer levels in combination with clinical risk factors can effectively predict subsequent thromboembolic events in patients with atrial fibrillation during oral anticoagulant therapy. Cardiology. 2010;117:31–6.
   PubMed Web of Science ®Google Scholar
• Nozawa T, Inoue H, Hirai T, Iwasa A, Okumura K, Lee JD, et al. D-dimer level influences thromboembolic events in patients with atrial fibrillation. Int J Cardiol. 2006;109:59–65.
   PubMed Web of Science ®Google Scholar
• Vene N, Mavri A, Kosmelj K, Stegnar M. High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy. Thromb Haemost. 2003;90:1163–72.
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Sakaguchi M, Okazaki S, Furukado S, Tagaya M, Etani H, et al. Relationship between plasma (D)-dimer level and cerebral infarction volume in patients with nonvalvular atrial fibrillation. Cerebrovasc Dis. 2013;35:64–72.
   PubMed Web of Science ®Google Scholar
• Lip GY, Rumley A, Dunn F, Lowe G. Plasma fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: effects of cardioversion to sinus rhythm. Int J Cardiol. 1995;51:245–51.
   PubMed Web of Science ®Google Scholar
• Hatzinikolaou-Kotsakou E, Hatseras DI. The potential of D-dimer levels as a useful clinical marker of clotting state after the return of sinus rhythm. Future Cardiol. 2006;2:55–61.
   Google Scholar
• Hatzinikolaou-Kotsakou E, Kartasis Z, Tziakas D, Stakos D, Hotidis A, Chalikias G, et al. Clotting state after cardioversion of atrial fibrillation: a haemostasis index could detect the relationship with the arrhythmia duration. Thromb J. 2005;3:2.
   PubMedGoogle Scholar
• Lip GY, Lip P, Zarifis J, Watson RD, Bareford D, Lowe GD, et al. Fibrin D-dimer and thrombomodulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin. Circulation. 1996;94:425–31.
   PubMed Web of Science ®Google Scholar
• Nakatani Y, Mizumaki K, Nishida K, Hirai T, Sakabe M, Oda Y, et al. Anticoagulation control quality affects the D-dimer levels of atrial fibrillation patients. Circ J. 2012;76:317–21.
   Google Scholar
• Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, et al. ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation: executive summary. Circulation. 2001;104: 2118–50.
   PubMed Web of Science ®Google Scholar
• Sairaku A, Yoshida Y, Hirayama H, Nakano Y, Kihara Y. Periprocedural coagulability in patients undergoing ablation of atrial fibrillation: lessons from a periablation anticoagulation strategy of a brief withdrawal of warfarin without heparin bridging. J Thromb Thrombolysis. 2014;37:393–9.
   Google Scholar
• Nin T, Sairaku A, Yoshida Y, Kamiya H, Tatematsu Y, Nanasato M, et al. A randomized controlled trial of dabigatran versus warfarin for periablation anticoagulation in patients undergoing ablation of atrial fibrillation. Pacing Clin Electrophysiol. 2013;36:172–9.
   PubMed Web of Science ®Google Scholar
• Tayebjee MH, Lip GY. Fibrin D-dimer levels in atrial fibrillation as an index of thrombogenesis: a possible test to exclude left atrial thrombus?Am J Cardiol. 2003;92:47–9.
   Google Scholar